Jeil Pharmaceutical Co.,Ltd (KRX:271980)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,380
-340 (-2.16%)
At close: Jun 27, 2025, 3:30 PM KST

KRX:271980 Ratios and Metrics

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
208,373166,115249,173306,279--
Upgrade
Market Cap Growth
-12.34%-33.33%-18.64%---
Upgrade
Enterprise Value
270,192219,930307,855346,439--
Upgrade
Last Close Price
14300.0011400.0017100.0020937.6133666.1062145.11
Upgrade
PE Ratio
--49.79---
Upgrade
PS Ratio
0.300.240.340.42--
Upgrade
PB Ratio
0.920.761.461.87--
Upgrade
P/TBV Ratio
1.130.911.621.99--
Upgrade
P/OCF Ratio
-51.70----
Upgrade
EV/Sales Ratio
0.390.310.420.48--
Upgrade
EV/EBITDA Ratio
270.82-16.50---
Upgrade
EV/EBIT Ratio
--34.64---
Upgrade
Debt / Equity Ratio
0.360.350.420.330.290.29
Upgrade
Debt / EBITDA Ratio
80.76-3.82--2.30
Upgrade
Debt / FCF Ratio
----3.48-
Upgrade
Asset Turnover
1.401.391.541.641.681.71
Upgrade
Inventory Turnover
4.754.925.195.615.155.53
Upgrade
Quick Ratio
0.820.790.660.710.780.75
Upgrade
Current Ratio
1.221.181.041.121.281.27
Upgrade
Return on Equity (ROE)
-11.82%-15.45%3.11%-9.06%-8.82%4.08%
Upgrade
Return on Assets (ROA)
-1.35%-2.29%1.18%-1.89%-1.55%1.92%
Upgrade
Return on Capital (ROIC)
-2.46%-4.32%2.41%-3.84%-2.97%3.67%
Upgrade
Return on Capital Employed (ROCE)
--4.90%--6.50%
Upgrade
Earnings Yield
-11.74%-18.04%2.01%-4.27%--
Upgrade
FCF Yield
-5.80%-0.64%-4.45%-8.57%--
Upgrade
Dividend Yield
--0.29%0.24%--
Upgrade
Payout Ratio
--14.55%--14.79%
Upgrade
Buyback Yield / Dilution
--0.02%0.23%0.04%0.41%
Upgrade
Total Shareholder Return
--0.31%0.47%0.04%0.41%
Upgrade
Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.